In 2023, the Hong Kong 18A market enters its fifth year of listing, and the fifth set of standards for the Sci-tech Innovation Board enters its fourth year. A total of 85 biotech companies have successfully gone public through this listing channel, driving the entire life science sector into high gear. Having experienced a boom and pursuit, as well as a cold winter and rationality, life science companies have never stopped innovating and breaking through. They continuously inject development momentum through technological innovation and bridge gaps through business model innovation. After experiencing dark moments, they still see themselves standing at new starting points and forging ahead.
From September 27th to 28th, 2023, Frost & Sullivan's (Frost & Sullivan, abbreviated as: Frost & Sullivan) second New Investment Expo and the 17th Frost & Sullivan Global Growth, Innovation, and Leadership Summit (abbreviated as "Frost & Sullivan New Investment Conference") will be grandly held at the Shangri-La Hotel in Pudong, Shanghai. The conference will introducethe New Life Science Investment Summit Forumwith the theme of“New Directions for the Future & Forge Ahead”bringing togetherindustry leaders, life science companies, investment institutions, and professional service organizationsto focus on new opportunities in life science investment and financing, and jointly discuss the capital and industrial forces for companies to navigate cycles.
We sincerely invite you to attend this forum and embark on the successful journey of the capital market for life science companies!
Time:September 27th - 28th, 2023
Venue:Shangri-La Hotel in Pudong, Shanghai
Sponsors:Frost & Sullivan, China Biomedical Industry Chain Innovation and Transformation Alliance (CBIITA)
01
Guest Profiles
02
Forum Agenda(Continuously updated)
03
GIL Awards Presentation
The Frost & Sullivan Growth, Innovation, and Leadership Awards (GILA) are based on the evaluation mechanism of the Frost & Sullivan Best Practice Awards, focusing on China and targeting the global market.
2023 marks the 62nd anniversary of Frost & Sullivan's global establishment and the 25th anniversary of entering the Chinese market. Frost & Sullivan China will continue to track and research a large number of successful cases of entrepreneurship and investment and financing in high-tech industries and strategic emerging industries within 2023, and conduct objective and in-depth analysis to comprehensively evaluate the innovation capabilities, business models, founding teams, technical capabilities, and development prospects of the participating companies. Together with a professional evaluation committee, they will finally select10 outstanding biotech companies.
04
Blue Book Release
At this conference
Frost & Sullivan will grandly release
The 2023 Hong Kong 18A & Sci-tech Innovation Board Biotech Industry Development Blue Book
Frost & Sullivan's compilation of The 2023 Hong Kong 18A & Sci-tech Innovation Board Biotech Industry Development Blue Book aims to sort out the ecosystem and industrial development pattern of the Hong Kong 18A and Sci-tech Innovation Board biotech industries for the Chinese industry community, and further provide cutting-edge insights to market participants. The release and exchange activities of the blue book will promote all parties in the market to deeply understand the industry's development environment, technological development direction, market opportunities, etc., jointly draw future trends in the biotech field with all parties in the market, and jointly promote the sustainable development of the biotech industry.
05
Consultation for Participation
Registration Consultation | Business Cooperation | Media Cooperation
Contact Person:
Ms. Li 18917935734 (same WeChat)
Ms. Bai 18019047843 (same WeChat)
06
Highlights from Previous Sessions
